Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Synchronous vascular endothelial growth factor protein profiles in both tissue and serum identify metastasis and poor survival in colorectal cancer.

Yeh CC, Shih LJ, Chang JL, Tsuei YW, Wu CC, Hsiao CW, Chuu CP, Kao YH.

Sci Rep. 2019 Mar 12;9(1):4228. doi: 10.1038/s41598-019-40862-6.

2.

Arecoline inhibits the growth of 3T3-L1 preadipocytes via AMP-activated protein kinase and reactive oxygen species pathways.

Tian ZH, Weng JT, Shih LJ, Siao AC, Chan TY, Tsuei YW, Kuo YC, Wang TS, Kao YH.

PLoS One. 2018 Jul 16;13(7):e0200508. doi: 10.1371/journal.pone.0200508. eCollection 2018.

3.

Proteome profiling reveals novel biomarkers to identify complicated parapneumonic effusions.

Wu KA, Wu CC, Chen CD, Chu CM, Shih LJ, Liu YC, Wang CL, Lin HH, Yang CY.

Sci Rep. 2017 Jun 22;7(1):4026. doi: 10.1038/s41598-017-04189-4.

4.

Differential effects of silencing crustacean hyperglycemic hormone gene expression on the metabolic profiles of the muscle and hepatopancreas in the crayfish Procambarus clarkii.

Li W, Chiu KH, Tien YC, Tsai SF, Shih LJ, Lee CH, Toullec JY, Lee CY.

PLoS One. 2017 Feb 16;12(2):e0172557. doi: 10.1371/journal.pone.0172557. eCollection 2017.

5.

Green tea (-)-epigallocatechin gallate induced growth inhibition of human placental choriocarcinoma cells.

Shih LJ, Lin YR, Lin CK, Liu HS, Kao YH.

Placenta. 2016 May;41:1-9. doi: 10.1016/j.placenta.2016.02.017. Epub 2016 Mar 2.

PMID:
27208402
6.

Green tea (-)-epigallocatechin gallate inhibits the growth of human villous trophoblasts via the ERK, p38, AMP-activated protein kinase, and protein kinase B pathways.

Shih LJ, Chen TF, Lin CK, Liu HS, Kao YH.

Am J Physiol Cell Physiol. 2016 Aug 1;311(2):C308-21. doi: 10.1152/ajpcell.00003.2016. Epub 2016 May 4.

7.

Green tea (-)-epigallocatechin gallate suppresses IGF-I and IGF-II stimulation of 3T3-L1 adipocyte glucose uptake via the glucose transporter 4, but not glucose transporter 1 pathway.

Ku HC, Tsuei YW, Kao CC, Weng JT, Shih LJ, Chang HH, Liu CW, Tsai SW, Kuo YC, Kao YH.

Gen Comp Endocrinol. 2014 Apr 1;199:46-55. doi: 10.1016/j.ygcen.2014.01.008. Epub 2014 Jan 28.

PMID:
24486085
8.

Green tea (-)-epigallocatechin gallate inhibits IGF-I and IGF-II stimulation of 3T3-L1 preadipocyte mitogenesis via the 67-kDa laminin receptor, but not AMP-activated protein kinase pathway.

Ku HC, Liu HS, Hung PF, Chen CL, Liu HC, Chang HH, Tsuei YW, Shih LJ, Lin CL, Lin CM, Kao YH.

Mol Nutr Food Res. 2012 Apr;56(4):580-92. doi: 10.1002/mnfr.201100438.

PMID:
22495985
9.

Green tea epigallocatechin gallate inhibits insulin stimulation of adipocyte glucose uptake via the 67-kilodalton laminin receptor and AMP-activated protein kinase pathways.

Hsieh CF, Tsuei YW, Liu CW, Kao CC, Shih LJ, Ho LT, Wu LY, Wu CP, Tsai PH, Chang HH, Ku HC, Kao YH.

Planta Med. 2010 Oct;76(15):1694-8. doi: 10.1055/s-0030-1249877. Epub 2010 May 7.

PMID:
20455202
10.

Green tea catechins: inhibitors of glycerol-3-phosphate dehydrogenase.

Kao CC, Wu BT, Tsuei YW, Shih LJ, Kuo YL, Kao YH.

Planta Med. 2010 May;76(7):694-6. doi: 10.1055/s-0029-1240623. Epub 2009 Nov 20.

PMID:
19937554
11.

Characterization of the agr2 gene, a homologue of X. laevis anterior gradient 2, from the zebrafish, Danio rerio.

Shih LJ, Lu YF, Chen YH, Lin CC, Chen JA, Hwang SP.

Gene Expr Patterns. 2007 Feb;7(4):452-60. Epub 2006 Nov 14.

PMID:
17175205
12.

Myosin heavy chain expression in cranial, pectoral fin, and tail muscle regions of zebrafish embryos.

Peng MY, Wen HJ, Shih LJ, Kuo CM, Hwang SP.

Mol Reprod Dev. 2002 Dec;63(4):422-9.

PMID:
12412043
13.

Identification and characterization of bone morphogenetic protein 2/4 gene from the starfish Archaster typicus.

Shih LJ, Chen CA, Chen CP, Hwang SP.

Comp Biochem Physiol B Biochem Mol Biol. 2002 Feb;131(2):143-51.

PMID:
11818237
14.

Expression of zebrafish Hoxa1a in neuronal cells of the midbrain and anterior hindbrain.

Shih LJ, Tsay HJ, Lin SC, Hwang SP.

Mech Dev. 2001 Mar;101(1-2):279-81.

15.

Effect of probenecid on the dose-response relationship of bumetanide at steady state.

Lau HS, Shih LJ, Smith DE.

J Pharmacol Exp Ther. 1983 Oct;227(1):51-4.

PMID:
6620171

Supplemental Content

Support Center